E

The weird, the wild, and the wonderful

A discussion of some of the key topics emerging in ER+ HER2- breast cancer

May 15, 2023
E

Is olaparib scaling new heights in OlympiA?

PARP inhibitors move into the adjuvant setting at long last? Say it ain't so!

June 3, 2021
E

The future of breast cancer research

Some key learnings from the ESMO Breast Cancer meeting held last week

May 10, 2021
E

A rock around the breast cancer clock

Highlights from various breast cancer trials and new pipeline developments

June 2, 2020
E

What’s new in advanced breast cancer?

There are a few new developments of note to consider from ESMO Breast this weekend plus more to come at ASCO20 on Friday

May 26, 2020
E

Will the next generation SERDs make an impact in ER+ HER2- breast cancer?

An in-depth look at the emerging SERD landscape in ER+ metastatic breast cancer

May 21, 2020
E

Gems from the EBCC10 Poster Hall

Review of 4 noteworthy posters at the 2016 European Breast Cancer Conference in Amsterdam organised by European Cancer Organisation ECCO

March 10, 2016